SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: SFX-01|DRUG: Fulvestrant|DRUG: Tamoxifen|DRUG: Aromatase Inhibitors
Sponsor: Evgen Pharma
Collaborators: Premier Research Group plc